Search Orphan Drug Designations and Approvals
-
Generic Name: | lixivaptan |
---|---|
Date Designated: | 09/18/2017 |
Orphan Designation: | Treatment of autosomal dominant polycystic kidney disease (ADPKD) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Palladio Biosciences, Inc. 12 Penns Trail Unit A Newtown, Pennsylvania 18940 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-